High‑Sensitivity Microfluidic Biochip for Advanced Diagnostic Detection (Microfluidic Biochip with Enhanced Sensitivity, Tech ID: 18‑005)
Technology Overview: This technology is a microfluidic biochip engineered for enhanced analytical sensitivity in biochemical and diagnostic applications. The device integrates optimized microchannel geometries and surface functionalization to increase target–analyte interactions while minimizing sample volumes. Its design enables precise fluid control, rapid assay times, and improved signal‑to‑noise ratios compared to conventional lab‑on‑a‑chip systems. The platform is adaptable to a wide range of biomarkers and detection modalities, making it suitable for point‑of‑care diagnostics and centralized laboratory testing.
Industry Pain Point: Many microfluidic devices suffer from limited sensitivity, requiring larger sample volumes or complex signal amplification.
NJIT Solution: This biochip delivers enhanced detection sensitivity through optimized microfluidic design and surface engineering.
Key Features & Advantages
- Enhanced signal‑to‑noise performance
- Low sample volume requirements
- Rapid assay turnaround
- Compatible with multiple biomarkers
Development Stage: TRL 5–6 – Functional prototypes validated.
Target Markets
- In‑vitro diagnostics
- Point‑of‑care testing
- Biomedical research tools
Market Opportunity
- Global microfluidics market (2026): ~$35B
- CAGR: ~13–14%
- Projected market size (2035): ~$95–100B
Commercial & IP Details
Inventors: Eon Soo Lee, Bharath Babu Nunna